| Circular RNAs in cancer: opportunities and challenges in the field |
243 |
| A novel protein encoded by the circular form of the SHPRH gene suppresses glioma tumorigenesis |
98 |
| Essential role of METTL3-mediated m(6)A modification in glioma stem-like cells maintenance and radioresistance |
86 |
| Dual role of autophagy in hallmarks of cancer |
84 |
| The m(6)A methyltransferase METTL3 promotes bladder cancer progression via AFF4/NF-kappa B/MYC signaling network |
73 |
| LncRNA PVT1 promotes angiogenesis via activating the STAT3/VEGFA axis in gastric cancer |
71 |
| Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies |
67 |
| Exosome circRNA secreted from adipocytes promotes the growth of hepatocellular carcinoma by targeting deubiquitination-related USP7 |
62 |
| YAP1-induced MALAT1 promotes epithelial-mesenchymal transition and angiogenesis by sponging miR-126-5p in colorectal cancer |
57 |
| Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis |
57 |
| Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players |
53 |
| Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations |
45 |
| Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a/Rora and miR-21/Pten Pathways |
44 |
| Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations |
44 |
| Tumor-derived exosomal lnc-Sox2ot promotes EMT and stemness by acting as a ceRNA in pancreatic ductal adenocarcinoma |
40 |
| LncRNA PVT1 regulates triple-negative breast cancer through KLF5/beta-catenin signaling |
38 |
| The ERK and JNK pathways in the regulation of metabolic reprogramming |
38 |
| Wild-type and mutated IDH1/2 enzymes and therapy responses |
38 |
| E-cadherin in contact inhibition and cancer |
38 |
| Hypoxia-induced LncRNA-BX111 promotes metastasis and progression of pancreatic cancer through regulating ZEB1 transcription |
36 |
| The dynamic and stress-adaptive signaling hub of 14-3-3: emerging mechanisms of regulation and context-dependent protein-protein interactions |
35 |
| Dynamic m(6)A mRNA methylation reveals the role of METTL3-m(6)A-CDCP1 signaling axis in chemical carcinogenesis |
35 |
| Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics |
35 |
| Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment |
34 |
| Connexins in cancer: bridging the gap to the clinic |
34 |
| MSC-regulated lncRNA MACC1-AS1 promotes stemness and chemoresistance through fatty acid oxidation in gastric cancer |
33 |
| The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumor microenvironment |
33 |
| WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer |
32 |
| Metastasis-associated miR-23a from nasopharyngeal carcinoma-derived exosomes mediates angiogenesis by repressing a novel target gene TSGA10 |
32 |
| KIAA1429 acts as an oncogenic factor in breast cancer by regulating CDK1 in an N6-methyladenosine-independent manner |
32 |
| A circular RNA circ-DNMT1 enhances breast cancer progression by activating autophagy |
32 |
| Epithelial-mesenchymal transition (EMT) beyond EGFR mutations per se is a common mechanism for acquired resistance to EGFR TKI |
32 |
| Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia |
32 |
| xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression |
31 |
| The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma |
31 |
| Exosomal Wnt-induced dedifferentiation of colorectal cancer cells contributes to chemotherapy resistance |
31 |
| Hypoxia-induced tumor exosomes promote M2-like macrophage polarization of infiltrating myeloid cells and microRNA-mediated metabolic shift |
31 |
| Epithelial-mesenchymal-transition-inducing transcription factors: new targets for tackling chemoresistance in cancer? |
30 |
| miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer |
29 |
| miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1 |
29 |
| Cancer-associated fibroblasts promote prostate cancer malignancy via metabolic rewiring and mitochondrial transfer |
29 |
| Microenvironmental oxygen pressure orchestrates an anti- and pro-tumoral gamma delta T cell equilibrium via tumor-derived exosomes |
29 |
| CPT1A-mediated fatty acid oxidation promotes colorectal cancer cell metastasis by inhibiting anoikis |
28 |
| Estrogen receptor beta promotes renal cell carcinoma progression via regulating LncRNA HOTAIR-miR-138/200c/204/217 associated CeRNA network |
28 |
| Hypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3/Rab proteins |
28 |
| The management of retinoblastoma |
27 |
| Upregulation of the long noncoding RNA FOXD2-AS1 promotes carcinogenesis by epigenetically silencing EphB3 through EZH2 and LSD and predicts poor prognosis in gastric cancer |
27 |
| Employing mesenchymal stem cells to support tumor-targeted delivery of extracellular vesicle (EV)-encapsulated microRNA-379 |
27 |
| Cisplatin-induced immune modulation in ovarian cancer mouse models with distinct inflammation profiles |
27 |
| Circular RNA profile identifies circOSBPL10 as an oncogenic factor and prognostic marker in gastric cancer |
27 |
